ID   PDK2_HUMAN              Reviewed;         407 AA.
AC   Q15119; A8K3A7; B3KNW0; Q6P515; Q9BS05;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-JUN-2002, sequence version 2.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial;
DE            EC=2.7.11.2;
DE   AltName: Full=Pyruvate dehydrogenase kinase isoform 2;
DE            Short=PDH kinase 2;
DE            Short=PDKII;
DE   Flags: Precursor;
GN   Name=PDK2; Synonyms=PDHK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7499431; DOI=10.1074/jbc.270.48.28989;
RA   Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M.;
RT   "Diversity of the pyruvate dehydrogenase kinase gene family in
RT   humans.";
RL   J. Biol. Chem. 270:28989-28994(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-342.
RC   TISSUE=Lung, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INDUCTION BY INSULIN, AND FUNCTION.
RX   PubMed=9787110; DOI=10.1006/mgme.1998.2748;
RA   Majer M., Popov K.M., Harris R.A., Bogardus C., Prochazka M.;
RT   "Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA:
RT   potential mechanism contributing to increased lipid oxidation in
RT   insulin-resistant subjects.";
RL   Mol. Genet. Metab. 65:181-186(1998).
RN   [7]
RP   SUBUNIT, AND INTERACTION WITH DLAT.
RX   PubMed=12816949; DOI=10.1074/jbc.M212733200;
RA   Hiromasa Y., Roche T.E.;
RT   "Facilitated interaction between the pyruvate dehydrogenase kinase
RT   isoform 2 and the dihydrolipoyl acetyltransferase.";
RL   J. Biol. Chem. 278:33681-33693(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, SUBUNIT, AND ENZYME REGULATION.
RX   PubMed=15491150; DOI=10.1021/bi049488x;
RA   Bao H., Kasten S.A., Yan X., Roche T.E.;
RT   "Pyruvate dehydrogenase kinase isoform 2 activity limited and further
RT   inhibited by slowing down the rate of dissociation of ADP.";
RL   Biochemistry 43:13432-13441(2004).
RN   [9]
RP   CATALYTIC ACTIVITY, INTERACTION WITH DLAT, SUBUNIT, AND ENZYME
RP   REGULATION.
RX   PubMed=16517984; DOI=10.1074/jbc.M513514200;
RA   Hiromasa Y., Hu L., Roche T.E.;
RT   "Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2.";
RL   J. Biol. Chem. 281:12568-12579(2006).
RN   [10]
RP   FUNCTION.
RX   PubMed=17222789; DOI=10.1016/j.ccr.2006.10.020;
RA   Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C.,
RA   Thompson R., Lee C.T., Lopaschuk G.D., Puttagunta L., Bonnet S.,
RA   Harry G., Hashimoto K., Porter C.J., Andrade M.A., Thebaud B.,
RA   Michelakis E.D.;
RT   "A mitochondria-K+ channel axis is suppressed in cancer and its
RT   normalization promotes apoptosis and inhibits cancer growth.";
RL   Cancer Cell 11:37-51(2007).
RN   [11]
RP   INDUCTION BY PPARD.
RX   PubMed=17669420; DOI=10.1016/j.jmb.2007.06.091;
RA   Degenhardt T., Saramaki A., Malinen M., Rieck M., Vaisanen S.,
RA   Huotari A., Herzig K.H., Muller R., Carlberg C.;
RT   "Three members of the human pyruvate dehydrogenase kinase gene family
RT   are direct targets of the peroxisome proliferator-activated receptor
RT   beta/delta.";
RL   J. Mol. Biol. 372:341-355(2007).
RN   [12]
RP   CATALYTIC ACTIVITY, FUNCTION, ENZYME REGULATION, INTERACTION WITH
RP   DLAT, AND SUBUNIT.
RX   PubMed=19833728; DOI=10.1074/jbc.M109.065557;
RA   Li J., Kato M., Chuang D.T.;
RT   "Pivotal role of the C-terminal DW-motif in mediating inhibition of
RT   pyruvate dehydrogenase kinase 2 by dichloroacetate.";
RL   J. Biol. Chem. 284:34458-34467(2009).
RN   [13]
RP   FUNCTION, AND INDUCTION BY CIGARETTE SMOKE EXTRACT AND REACTIVE OXYGEN
RP   SPECIES.
RX   PubMed=21283817; DOI=10.1371/journal.pone.0016207;
RA   Sun W., Chang S.S., Fu Y., Liu Y., Califano J.A.;
RT   "Chronic CSE treatment induces the growth of normal oral keratinocytes
RT   via PDK2 upregulation, increased glycolysis and HIF1alpha
RT   stabilization.";
RL   PLoS ONE 6:E16207-E16207(2011).
RN   [14]
RP   FUNCTION.
RX   PubMed=22123926; DOI=10.1158/0008-5472.CAN-11-1215;
RA   Contractor T., Harris C.R.;
RT   "p53 negatively regulates transcription of the pyruvate dehydrogenase
RT   kinase Pdk2.";
RL   Cancer Res. 72:560-567(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 16-407 IN COMPLEX WITH ATP
RP   AND THE INHIBITORS AZD7545; NOV3R; PFZ3 AND DICHLOROACETATE.
RX   PubMed=16401071; DOI=10.1021/bi051402s;
RA   Knoechel T.R., Tucker A.D., Robinson C.M., Phillips C., Taylor W.,
RA   Bungay P.J., Kasten S.A., Roche T.E., Brown D.G.;
RT   "Regulatory roles of the N-terminal domain based on crystal structures
RT   of human pyruvate dehydrogenase kinase 2 containing physiological and
RT   synthetic ligands.";
RL   Biochemistry 45:402-415(2006).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase that plays a key role in the regulation of
CC       glucose and fatty acid metabolism and homeostasis via
CC       phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and
CC       PDHA2. This inhibits pyruvate dehydrogenase activity, and thereby
CC       regulates metabolite flux through the tricarboxylic acid cycle,
CC       down-regulates aerobic respiration and inhibits the formation of
CC       acetyl-coenzyme A from pyruvate. Inhibition of pyruvate
CC       dehydrogenase decreases glucose utilization and increases fat
CC       metabolism. Mediates cellular responses to insulin. Plays an
CC       important role in maintaining normal blood glucose levels and in
CC       metabolic adaptation to nutrient availability. Via its regulation
CC       of pyruvate dehydrogenase activity, plays an important role in
CC       maintaining normal blood pH and in preventing the accumulation of
CC       ketone bodies under starvation. Plays a role in the regulation of
CC       cell proliferation and in resistance to apoptosis under oxidative
CC       stress. Plays a role in p53/TP53-mediated apoptosis.
CC       {ECO:0000269|PubMed:17222789, ECO:0000269|PubMed:19833728,
CC       ECO:0000269|PubMed:21283817, ECO:0000269|PubMed:22123926,
CC       ECO:0000269|PubMed:7499431, ECO:0000269|PubMed:9787110}.
CC   -!- CATALYTIC ACTIVITY: ATP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] = ADP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] phosphate. {ECO:0000269|PubMed:15491150,
CC       ECO:0000269|PubMed:16517984, ECO:0000269|PubMed:19833728,
CC       ECO:0000269|PubMed:7499431}.
CC   -!- ENZYME REGULATION: Activity is enhanced by binding to the pyruvate
CC       dehydrogenase subunit DLAT. Inhibited by ADP and pyruvate; these
CC       compounds interfere with DLAT binding and thereby inhibit kinase
CC       activity. Inhibited by dichloroacetate. Inhibited by AZD7545; this
CC       compound interferes with DLAT binding and thereby inhibits kinase
CC       activity. {ECO:0000269|PubMed:15491150,
CC       ECO:0000269|PubMed:16517984, ECO:0000269|PubMed:19833728}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with PDK1. Interacts with the
CC       pyruvate dehydrogenase complex subunit DLAT, and is part of the
CC       multimeric pyruvate dehydrogenase complex that contains multiple
CC       copies of pyruvate dehydrogenase (E1), dihydrolipoamide
CC       acetyltransferase (DLAT, E2) and lipoamide dehydrogenase (DLD,
CC       E3). {ECO:0000269|PubMed:12816949, ECO:0000269|PubMed:15491150,
CC       ECO:0000269|PubMed:16401071, ECO:0000269|PubMed:16517984,
CC       ECO:0000269|PubMed:19833728}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15119-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15119-2; Sequence=VSP_042549;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues, with the highest
CC       level in heart and skeletal muscle, intermediate levels in brain,
CC       kidney, pancreas and liver, and low levels in placenta and lung.
CC       {ECO:0000269|PubMed:7499431}.
CC   -!- INDUCTION: Down-regulated by insulin. Up-regulated by reactive
CC       oxygen species and cigarette smoke extract. Up-regulated by PPARD.
CC       {ECO:0000269|PubMed:17669420, ECO:0000269|PubMed:21283817,
CC       ECO:0000269|PubMed:9787110}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42451; AAC42010.1; -; mRNA.
DR   EMBL; AK055119; BAG51472.1; -; mRNA.
DR   EMBL; AK290522; BAF83211.1; -; mRNA.
DR   EMBL; AC002401; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94642.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94644.1; -; Genomic_DNA.
DR   EMBL; BC005811; AAH05811.1; -; mRNA.
DR   EMBL; BC040478; AAH40478.1; -; mRNA.
DR   EMBL; BC063137; AAH63137.1; -; mRNA.
DR   CCDS; CCDS11559.1; -. [Q15119-1]
DR   CCDS; CCDS56039.1; -. [Q15119-2]
DR   PIR; I70159; I70159.
DR   RefSeq; NP_001186827.1; NM_001199898.1. [Q15119-2]
DR   RefSeq; NP_001186828.1; NM_001199899.1. [Q15119-2]
DR   RefSeq; NP_002602.2; NM_002611.4. [Q15119-1]
DR   UniGene; Hs.256667; -.
DR   PDB; 2BTZ; X-ray; 2.20 A; A=16-407.
DR   PDB; 2BU2; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU5; X-ray; 2.35 A; A=16-407.
DR   PDB; 2BU6; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU7; X-ray; 2.40 A; A=16-407.
DR   PDB; 2BU8; X-ray; 2.50 A; A=16-407.
DR   PDB; 4MP2; X-ray; 1.75 A; A=9-407.
DR   PDB; 4MP7; X-ray; 1.80 A; A=9-407.
DR   PDB; 4MPC; X-ray; 1.70 A; A=9-407.
DR   PDB; 4MPE; X-ray; 1.95 A; A=9-407.
DR   PDB; 4MPN; X-ray; 1.75 A; A=9-407.
DR   PDB; 4V25; X-ray; 2.60 A; A=1-407.
DR   PDB; 4V26; X-ray; 2.49 A; A=1-407.
DR   PDB; 5J6A; X-ray; 2.04 A; A=9-407.
DR   PDB; 5J71; X-ray; 1.65 A; A=9-407.
DR   PDB; 5M4K; X-ray; 2.60 A; A=1-407.
DR   PDB; 5M4M; X-ray; 2.40 A; A=1-407.
DR   PDB; 5M4N; X-ray; 2.60 A; A=1-407.
DR   PDB; 5M4P; X-ray; 2.30 A; A=1-407.
DR   PDBsum; 2BTZ; -.
DR   PDBsum; 2BU2; -.
DR   PDBsum; 2BU5; -.
DR   PDBsum; 2BU6; -.
DR   PDBsum; 2BU7; -.
DR   PDBsum; 2BU8; -.
DR   PDBsum; 4MP2; -.
DR   PDBsum; 4MP7; -.
DR   PDBsum; 4MPC; -.
DR   PDBsum; 4MPE; -.
DR   PDBsum; 4MPN; -.
DR   PDBsum; 4V25; -.
DR   PDBsum; 4V26; -.
DR   PDBsum; 5J6A; -.
DR   PDBsum; 5J71; -.
DR   PDBsum; 5M4K; -.
DR   PDBsum; 5M4M; -.
DR   PDBsum; 5M4N; -.
DR   PDBsum; 5M4P; -.
DR   ProteinModelPortal; Q15119; -.
DR   SMR; Q15119; -.
DR   BioGrid; 111190; 14.
DR   IntAct; Q15119; 9.
DR   MINT; MINT-1379180; -.
DR   STRING; 9606.ENSP00000420927; -.
DR   BindingDB; Q15119; -.
DR   ChEMBL; CHEMBL3861; -.
DR   DrugBank; DB08610; N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE.
DR   GuidetoPHARMACOLOGY; 2142; -.
DR   iPTMnet; Q15119; -.
DR   PhosphoSitePlus; Q15119; -.
DR   BioMuta; PDK2; -.
DR   DMDM; 21431820; -.
DR   EPD; Q15119; -.
DR   MaxQB; Q15119; -.
DR   PaxDb; Q15119; -.
DR   PeptideAtlas; Q15119; -.
DR   PRIDE; Q15119; -.
DR   DNASU; 5164; -.
DR   Ensembl; ENST00000007708; ENSP00000007708; ENSG00000005882. [Q15119-2]
DR   Ensembl; ENST00000503176; ENSP00000420927; ENSG00000005882. [Q15119-1]
DR   Ensembl; ENST00000614357; ENSP00000481915; ENSG00000005882. [Q15119-2]
DR   GeneID; 5164; -.
DR   KEGG; hsa:5164; -.
DR   UCSC; uc002iqb.4; human. [Q15119-1]
DR   CTD; 5164; -.
DR   DisGeNET; 5164; -.
DR   GeneCards; PDK2; -.
DR   HGNC; HGNC:8810; PDK2.
DR   HPA; HPA008287; -.
DR   MIM; 602525; gene.
DR   neXtProt; NX_Q15119; -.
DR   OpenTargets; ENSG00000005882; -.
DR   PharmGKB; PA33155; -.
DR   eggNOG; KOG0787; Eukaryota.
DR   eggNOG; COG0642; LUCA.
DR   GeneTree; ENSGT00550000074574; -.
DR   HOGENOM; HOG000164315; -.
DR   HOVERGEN; HBG000511; -.
DR   InParanoid; Q15119; -.
DR   KO; K00898; -.
DR   OMA; AFHSAKM; -.
DR   OrthoDB; EOG091G07DJ; -.
DR   PhylomeDB; Q15119; -.
DR   TreeFam; TF314918; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SignaLink; Q15119; -.
DR   SIGNOR; Q15119; -.
DR   ChiTaRS; PDK2; human.
DR   EvolutionaryTrace; Q15119; -.
DR   GeneWiki; PDK2; -.
DR   GenomeRNAi; 5164; -.
DR   PRO; PR:Q15119; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000005882; -.
DR   CleanEx; HS_PDK2; -.
DR   ExpressionAtlas; Q15119; baseline and differential.
DR   Genevisible; Q15119; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB.
DR   GO; GO:0031670; P:cellular response to nutrient; ISS:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IMP:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; ISS:UniProtKB.
DR   GO; GO:0010565; P:regulation of cellular ketone metabolic process; ISS:UniProtKB.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; ISS:UniProtKB.
DR   GO; GO:0006885; P:regulation of pH; ISS:UniProtKB.
DR   Gene3D; 1.20.140.20; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR005467; His_kinase_dom.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF69012; SSF69012; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Carbohydrate metabolism; Complete proteome; Glucose metabolism;
KW   Kinase; Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    407       [Pyruvate dehydrogenase (acetyl-
FT                                transferring)] kinase isozyme 2,
FT                                mitochondrial.
FT                                /FTId=PRO_0000023440.
FT   DOMAIN      135    364       Histidine kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00107}.
FT   NP_BIND     251    258       ATP. {ECO:0000269|PubMed:16401071}.
FT   NP_BIND     309    310       ATP. {ECO:0000250}.
FT   NP_BIND     325    330       ATP. {ECO:0000269|PubMed:16401071}.
FT   BINDING     290    290       ATP. {ECO:0000269|PubMed:16401071}.
FT   MOD_RES     215    215       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q15118}.
FT   MOD_RES     216    216       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q15118}.
FT   MOD_RES     376    376       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BFP9}.
FT   VAR_SEQ       1     64       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042549.
FT   VARIANT     342    342       G -> R (in a glioblastoma multiforme
FT                                sample; somatic mutation;
FT                                dbSNP:rs17855787).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042296.
FT   CONFLICT     80     80       S -> T (in Ref. 1; AAC42010).
FT                                {ECO:0000305}.
FT   CONFLICT    407    407       S -> T (in Ref. 1; AAC42010).
FT                                {ECO:0000305}.
FT   HELIX        13     15       {ECO:0000244|PDB:5J6A}.
FT   HELIX        16     24       {ECO:0000244|PDB:5J71}.
FT   HELIX        33     37       {ECO:0000244|PDB:5J71}.
FT   STRAND       41     43       {ECO:0000244|PDB:2BTZ}.
FT   HELIX        46     68       {ECO:0000244|PDB:5J71}.
FT   HELIX        73     76       {ECO:0000244|PDB:5J71}.
FT   HELIX        79     96       {ECO:0000244|PDB:5J71}.
FT   TURN         97    100       {ECO:0000244|PDB:5J71}.
FT   STRAND      103    105       {ECO:0000244|PDB:5M4K}.
FT   HELIX       106    122       {ECO:0000244|PDB:5J71}.
FT   TURN        123    125       {ECO:0000244|PDB:5J71}.
FT   HELIX       126    141       {ECO:0000244|PDB:5J71}.
FT   HELIX       145    175       {ECO:0000244|PDB:5J71}.
FT   STRAND      177    179       {ECO:0000244|PDB:2BU8}.
FT   STRAND      191    196       {ECO:0000244|PDB:5J71}.
FT   HELIX       197    216       {ECO:0000244|PDB:5J71}.
FT   STRAND      222    230       {ECO:0000244|PDB:5J71}.
FT   STRAND      237    240       {ECO:0000244|PDB:5J71}.
FT   HELIX       242    262       {ECO:0000244|PDB:5J71}.
FT   TURN        263    266       {ECO:0000244|PDB:5J71}.
FT   STRAND      273    279       {ECO:0000244|PDB:5J71}.
FT   STRAND      281    290       {ECO:0000244|PDB:5J71}.
FT   HELIX       297    299       {ECO:0000244|PDB:5J71}.
FT   HELIX       301    304       {ECO:0000244|PDB:5J71}.
FT   TURN        306    309       {ECO:0000244|PDB:4MPC}.
FT   HELIX       323    325       {ECO:0000244|PDB:4V26}.
FT   STRAND      326    328       {ECO:0000244|PDB:5M4P}.
FT   HELIX       329    339       {ECO:0000244|PDB:5J71}.
FT   STRAND      343    349       {ECO:0000244|PDB:5J71}.
FT   TURN        350    352       {ECO:0000244|PDB:5J71}.
FT   STRAND      353    363       {ECO:0000244|PDB:5J71}.
FT   TURN        364    366       {ECO:0000244|PDB:5J71}.
FT   HELIX       376    381       {ECO:0000244|PDB:5J71}.
SQ   SEQUENCE   407 AA;  46154 MW;  77DBA03EF922EF03 CRC64;
     MRWVWALLKN ASLAGAPKYI EHFSKFSPSP LSMKQFLDFG SSNACEKTSF TFLRQELPVR
     LANIMKEINL LPDRVLSTPS VQLVQSWYVQ SLLDIMEFLD KDPEDHRTLS QFTDALVTIR
     NRHNDVVPTM AQGVLEYKDT YGDDPVSNQN IQYFLDRFYL SRISIRMLIN QHTLIFDGST
     NPAHPKHIGS IDPNCNVSEV VKDAYDMAKL LCDKYYMASP DLEIQEINAA NSKQPIHMVY
     VPSHLYHMLF ELFKNAMRAT VESHESSLIL PPIKVMVALG EEDLSIKMSD RGGGVPLRKI
     ERLFSYMYST APTPQPGTGG TPLAGFGYGL PISRLYAKYF QGDLQLFSME GFGTDAVIYL
     KALSTDSVER LPVYNKSAWR HYQTIQEAGD WCVPSTEPKN TSTYRVS
//
